Lucid Diagnostics Inc. (NASDAQ: LUCD)
$0.89
+0.0123 ( +1.41% ) 24.3K
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Market Data
Open
$0.89
Previous close
$0.87
Volume
24.3K
Market cap
$45.86M
Day range
$0.85 - $0.89
52 week range
$0.63 - $1.72
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 08, 2024 |
4 | Insider transactions | 1 | May 08, 2024 |
8-k | 8K-related | 16 | May 07, 2024 |
8-k | 8K-related | 14 | May 02, 2024 |
def | Proxies and info statements | 3 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
pre | Proxies and info statements | 3 | Apr 19, 2024 |
10-k | Annual reports | 100 | Mar 25, 2024 |
8-k | 8K-related | 18 | Mar 14, 2024 |
4 | Insider transactions | 2 | Feb 23, 2024 |